e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pharmacological modulation of biomarkers and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
F. Kellett, R. Niven (Warrington, United Kingdom)
Source:
Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Session:
Pharmacological modulation of biomarkers and management
Session type:
Thematic Poster Session
Number:
4587
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Kellett, R. Niven (Warrington, United Kingdom). Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 4587
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma
Source: Eur Respir J 2011; 37: 342
Year: 2011
Airway surface pH in subjects with cystic fibrosis
Source: Eur Respir J 2003; 21: 37-42
Year: 2003
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
The assesment of aerosol solution lung deposition in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Different hypertonic sodium chloride solution influence on external respiratory function in chronic obstructive lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 181s
Year: 2002
Inhaled mannitol as treatment for children with cystic fibrosis
Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Year: 2008
Comparative evaluation of mucociliary clearance in patients with mucoviscedosis and chronic obstructive bronchitis and one influence of hypertonic sodium chloride concentrations on it
Source: Eur Respir J 2001; 18: Suppl. 33, 124s
Year: 2001
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis
Source: Eur Respir J 2002; 19: 294-302
Year: 2002
Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining
Year: 2011
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Source: Eur Respir J 2004; 24: 95-100
Year: 2004
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Source: Eur Respir J 2012; 40: 61-66
Year: 2012
Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 450s
Year: 2007
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway
Source: Eur Respir J 2010; 35: 781-786
Year: 2010
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018
Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis
Source: Eur Respir J 2008; 31: 765-772
Year: 2008
Optimising inhaled mannitol for cystic fibrosis in an adult population
Source: Breathe 2015; 11:39-48
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept